Softer More Frequent Stools in Infants With Difficult Stooling Fed Hydrolyzed Protein Formula With Added Prebiotics:

Veronica Fabrizio1,2, Cheryl L Harris1, Kelly R Walsh1

  • 1Medical and Scientific Affairs, Reckitt | Mead Johnson Nutrition Institute (MJNI), Evansville, IN, United States.

Insights

A new partially hydrolyzed protein infant formula with prebiotics effectively softened stools and increased frequency in infants experiencing constipation. This formula was well-tolerated and showed no significant differences in adverse events compared to standard formula.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Nutrition Science

Background:

  • Infant constipation is a common concern, impacting infant well-being and parental stress.
  • Standard infant formulas may contribute to hard stools, necessitating specialized formulations.
  • Prebiotics are known to influence gut microbiota and stool consistency.

Purpose of the Study:

  • To evaluate the efficacy of a partially hydrolyzed protein (PHF) infant formula with added prebiotics in softening stools.
  • To assess stool frequency and other infant outcomes in a randomized controlled trial.

Main Methods:

  • A multi-center, double-blind, controlled study randomized infants (28-300 days) to PHF or intact protein formula for 14 days.
  • Both formulas contained a prebiotic blend (polydextrose and galactooligosaccharides).
  • Parent-reported stool consistency (1=hard, 5=watery) and frequency were primary outcomes.

Main Results:

  • Infants fed PHF formula had significantly softer stools (3.4 vs 3.0, P=0.019) and higher stool frequency (1.5 vs 1.0, P=0.002) compared to controls at study end.
  • Stool consistency improved within the first 3 days of feeding in both groups.
  • Crying, fussing, and pain during stooling decreased from baseline in both groups.

Conclusions:

  • A partially hydrolyzed protein infant formula with prebiotics is well-tolerated.
  • This specialized formula effectively softens stools and increases stool frequency in infants with constipation.
  • The formula offers a beneficial option for managing infant constipation and improving comfort.
Abstract

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
320
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
288
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
404
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
435
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
316
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
232